These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Anthenelli RM; Morris C; Ramey TS; Dubrava SJ; Tsilkos K; Russ C; Yunis C Ann Intern Med; 2013 Sep; 159(6):390-400. PubMed ID: 24042367 [TBL] [Abstract][Full Text] [Related]
27. Worsening psychosis induced by varenicline in a hospitalized psychiatric patient. DiPaula BA; Thomas MD Pharmacotherapy; 2009 Jul; 29(7):852-7. PubMed ID: 19558259 [TBL] [Abstract][Full Text] [Related]
29. [New tobacco dependence drug: Varenicline, partial agonist of alpha4beta2 acetylcholine-nicotine receptors]. Králíková E Cas Lek Cesk; 2006; 145(11):832-4. PubMed ID: 17168413 [TBL] [Abstract][Full Text] [Related]
30. A longer course of varenicline therapy improves smoking cessation rates. Lee JH; Jones PG; Bybee K; O'Keefe JH Prev Cardiol; 2008; 11(4):210-4. PubMed ID: 19476573 [TBL] [Abstract][Full Text] [Related]
31. Varenicline (Chantix) warnings: risk versus benefit. Med Lett Drugs Ther; 2008 Jul; 50(1290):53. PubMed ID: 18617873 [No Abstract] [Full Text] [Related]
32. Quitting smoking without a psychotic break: the potential link between nicotinic acetylcholine receptor partial agonists and neuropsychiatric adverse events. O'Malley P Clin Nurse Spec; 2009; 23(1):13-5. PubMed ID: 19098509 [No Abstract] [Full Text] [Related]
33. Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia. Ismail Z; Syms J; Blumberger D; George TP Schizophr Res; 2010 Jun; 119(1-3):268. PubMed ID: 20178890 [No Abstract] [Full Text] [Related]
34. Acute hepatic injury associated with varenicline in a patient with underlying liver disease. Franck AJ; Sliter LR Ann Pharmacother; 2009 Sep; 43(9):1539-43. PubMed ID: 19638471 [TBL] [Abstract][Full Text] [Related]
35. [Good effect of varenicline in snuff use cessation. Double-blind placebo controlled comparative study]. Fagerström KO; Gilljam H; Tonstad S Lakartidningen; 2011 Nov 2-8; 108(44):2215-7. PubMed ID: 22165180 [No Abstract] [Full Text] [Related]
36. Molecule of the Month. Varenicline tartrate. Drug News Perspect; 2006 Apr; 19(3):162. PubMed ID: 16804568 [No Abstract] [Full Text] [Related]
37. The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review. Crunelle CL; Miller ML; Booij J; van den Brink W Eur Neuropsychopharmacol; 2010 Feb; 20(2):69-79. PubMed ID: 19959340 [TBL] [Abstract][Full Text] [Related]
38. Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers. McColl SL; Burstein AH; Reeves KR; Billing CB; Stolar M; Sellers EM Clin Pharmacol Ther; 2008 Apr; 83(4):607-14. PubMed ID: 18288085 [TBL] [Abstract][Full Text] [Related]
39. A case of late-life onset mania during Varenicline assisted smoking cessation. Francois D; Odom A; Kotbi N Int J Geriatr Psychiatry; 2011 Jun; 26(6):658-9. PubMed ID: 21480382 [No Abstract] [Full Text] [Related]
40. Single- and multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy Japanese adult smokers. Kikkawa H; Maruyama N; Fujimoto Y; Hasunuma T J Clin Pharmacol; 2011 Apr; 51(4):527-37. PubMed ID: 20551220 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]